CD44 and colorectal carcinoma: The synergistic effect of curcumin and dasatinib also significantly reduced CSC population as shown by the downregulation of CSC-specific markers (ALDH, CD44, CD133, and CD166) in FOLFOX-resistant CRC cells [65].